Pindolol
Pindolol is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Pindolol; Generic name: PINDOLOL; Drug class: beta-Adrenergic Blocker [EPC].
| Brand name | Pindolol |
|---|---|
| Generic name | PINDOLOL |
| Drug class | beta-Adrenergic Blocker [EPC] |
| Manufacturer | PD-Rx Pharmaceuticals, Inc. |
| Used for | INDICATIONS AND USAGE Pindolol tablets are indicated in the management of hypertension. It may be used alone or concomitantly with other antihypertensive agents, particularly with a thiazide-type diuretic. |
| Dosage | DOSAGE AND ADMINISTRATION The dosage of pindolol tablets should be individualized. The recommended initial dose of pindolol tablets is 5 mg b.i.d. alone or in combination with other antihypertensive agents. An antihypertensive response usually occurs within the first week of treatment. Maximal response, however, may take as long as or occasionally longer than 2 weeks. If a satisfactory reduction in blood pressure does not occur within 3 to 4 weeks, the dose may be adjusted in increments of 10 mg |
| Warnings | WARNINGS Cardiac Failure Sympathetic stimulation may be a vital component supporting circulatory function in patients with congestive heart failure, and its inhibition by beta-blockade may precipitate more severe failure. Although beta-blockers should be avoided in overt congestive heart failure, if necessary, pindolol can be used with caution in patients with a history of failure who are well-compensated, usually with digitalis and diuretics. Both digitalis glycosides and beta-blockers slow atr |
| Active ingredient(s) | PINDOLOL |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0daed7b3-6017-4611-8c3a-2f390470f8bc |